193 related articles for article (PubMed ID: 30370059)
1. USP7 deubiquitinates and stabilizes NOTCH1 in T-cell acute lymphoblastic leukemia.
Shan H; Li X; Xiao X; Dai Y; Huang J; Song J; Liu M; Yang L; Lei H; Tong Y; Zhou L; Xu H; Wu Y
Signal Transduct Target Ther; 2018; 3():29. PubMed ID: 30370059
[TBL] [Abstract][Full Text] [Related]
2. USP7 Cooperates with NOTCH1 to Drive the Oncogenic Transcriptional Program in T-Cell Leukemia.
Jin Q; Martinez CA; Arcipowski KM; Zhu Y; Gutierrez-Diaz BT; Wang KK; Johnson MR; Volk AG; Wang F; Wu J; Grove C; Wang H; Sokirniy I; Thomas PM; Goo YA; Abshiru NA; Hijiya N; Peirs S; Vandamme N; Berx G; Goosens S; Marshall SA; Rendleman EJ; Takahashi YH; Wang L; Rawat R; Bartom ET; Collings CK; Van Vlierberghe P; Strikoudis A; Kelly S; Ueberheide B; Mantis C; Kandela I; Bourquin JP; Bornhauser B; Serafin V; Bresolin S; Paganin M; Accordi B; Basso G; Kelleher NL; Weinstock J; Kumar S; Crispino JD; Shilatifard A; Ntziachristos P
Clin Cancer Res; 2019 Jan; 25(1):222-239. PubMed ID: 30224337
[TBL] [Abstract][Full Text] [Related]
3. USP7 is a novel Deubiquitinase sustaining PLK1 protein stability and regulating chromosome alignment in mitosis.
Peng Y; Liu Y; Gao Y; Yuan B; Qi X; Fu Y; Zhu Q; Cao T; Zhang S; Yin L; Li X
J Exp Clin Cancer Res; 2019 Nov; 38(1):468. PubMed ID: 31730000
[TBL] [Abstract][Full Text] [Related]
4. Mixed Lineage Leukemia 5 (MLL5) Protein Stability Is Cooperatively Regulated by O-GlcNac Transferase (OGT) and Ubiquitin Specific Protease 7 (USP7).
Ding X; Jiang W; Zhou P; Liu L; Wan X; Yuan X; Wang X; Chen M; Chen J; Yang J; Kong C; Li B; Peng C; Wong CC; Hou F; Zhang Y
PLoS One; 2015; 10(12):e0145023. PubMed ID: 26678539
[TBL] [Abstract][Full Text] [Related]
5. USP7 Deubiquitinates and Stabilizes SIRT1.
Song N; Cao C; Tian S; Long M; Liu L
Anat Rec (Hoboken); 2020 May; 303(5):1337-1345. PubMed ID: 31502386
[TBL] [Abstract][Full Text] [Related]
6. T cell acute lymphoblastic leukemia/lymphoma: a human cancer commonly associated with aberrant NOTCH1 signaling.
Pear WS; Aster JC
Curr Opin Hematol; 2004 Nov; 11(6):426-33. PubMed ID: 15548998
[TBL] [Abstract][Full Text] [Related]
7. Protein deubiquitinase USP7 is required for osteogenic differentiation of human adipose-derived stem cells.
Tang Y; Lv L; Li W; Zhang X; Jiang Y; Ge W; Zhou Y
Stem Cell Res Ther; 2017 Aug; 8(1):186. PubMed ID: 28807012
[TBL] [Abstract][Full Text] [Related]
8. New insights into Notch1 regulation of the PI3K-AKT-mTOR1 signaling axis: targeted therapy of γ-secretase inhibitor resistant T-cell acute lymphoblastic leukemia.
Hales EC; Taub JW; Matherly LH
Cell Signal; 2014 Jan; 26(1):149-61. PubMed ID: 24140475
[TBL] [Abstract][Full Text] [Related]
9. USP7 inhibitor P5091 inhibits Wnt signaling and colorectal tumor growth.
An T; Gong Y; Li X; Kong L; Ma P; Gong L; Zhu H; Yu C; Liu J; Zhou H; Mao B; Li Y
Biochem Pharmacol; 2017 May; 131():29-39. PubMed ID: 28216017
[TBL] [Abstract][Full Text] [Related]
10. USP7 deubiquitinase promotes ubiquitin-dependent DNA damage signaling by stabilizing RNF168.
Zhu Q; Sharma N; He J; Wani G; Wani AA
Cell Cycle; 2015; 14(9):1413-25. PubMed ID: 25894431
[TBL] [Abstract][Full Text] [Related]
11. USP7-TRIM27 axis negatively modulates antiviral type I IFN signaling.
Cai J; Chen HY; Peng SJ; Meng JL; Wang Y; Zhou Y; Qian XP; Sun XY; Pang XW; Zhang Y; Zhang J
FASEB J; 2018 Oct; 32(10):5238-5249. PubMed ID: 29688809
[TBL] [Abstract][Full Text] [Related]
12. mTORC1 accelerates osteosarcoma progression via m
Yang Z; Yu W; Xu A; Liu B; Jin L; Tao H; Wang D
Cell Death Discov; 2024 Mar; 10(1):127. PubMed ID: 38467635
[TBL] [Abstract][Full Text] [Related]
13. FOXP3 knockdown inhibits the proliferation and reduces NOTCH1 expression of T cell acute lymphoblastic leukemia cells.
Yonekura S; Itoh M; Shiratori E; Ohtaka M; Tohda S
BMC Res Notes; 2018 Aug; 11(1):582. PubMed ID: 30103821
[TBL] [Abstract][Full Text] [Related]
14. USP7 inhibition induces apoptosis in glioblastoma by enhancing ubiquitination of ARF4.
Pan T; Li X; Li Y; Tao Z; Yao H; Wu Y; Chen G; Zhang K; Zhou Y; Huang Y
Cancer Cell Int; 2021 Sep; 21(1):508. PubMed ID: 34556124
[TBL] [Abstract][Full Text] [Related]
15. Flavone inhibited proliferation of T-ALL by promoting c-Cbl-induced ubiquitinylation and degradation of Notch1.
Zhu W; Zhu Y; Xu H; Wang T; Wang J; Meng M; Liu Y; Yan H; Yang Q; Liu P
Biochem Biophys Res Commun; 2020 Feb; 522(3):684-689. PubMed ID: 31785807
[TBL] [Abstract][Full Text] [Related]
16. Preclinical testing of CT1113, a novel USP28 inhibitor, for the treatment of T-cell acute lymphoblastic leukaemia.
Xu J; Peng J; Sun S; Wang D; Yuan W; Yang X; Shi T; Wang R; Liu H; Zhang P; Zhu HH
Br J Haematol; 2024 Jun; 204(6):2301-2318. PubMed ID: 38685813
[TBL] [Abstract][Full Text] [Related]
17. An Allosteric Interaction Links USP7 to Deubiquitination and Chromatin Targeting of UHRF1.
Zhang ZM; Rothbart SB; Allison DF; Cai Q; Harrison JS; Li L; Wang Y; Strahl BD; Wang GG; Song J
Cell Rep; 2015 Sep; 12(9):1400-6. PubMed ID: 26299963
[TBL] [Abstract][Full Text] [Related]
18. The USP7 protein interaction network and its roles in tumorigenesis.
Al-Eidan A; Wang Y; Skipp P; Ewing RM
Genes Dis; 2022 Jan; 9(1):41-50. PubMed ID: 35005106
[TBL] [Abstract][Full Text] [Related]
19. Molecular Understanding of USP7 Substrate Recognition and C-Terminal Activation.
Rougé L; Bainbridge TW; Kwok M; Tong R; Di Lello P; Wertz IE; Maurer T; Ernst JA; Murray J
Structure; 2016 Aug; 24(8):1335-1345. PubMed ID: 27452404
[TBL] [Abstract][Full Text] [Related]
20. In vitro validation of gamma-secretase inhibitors alone or in combination with other anti-cancer drugs for the treatment of T-cell acute lymphoblastic leukemia.
De Keersmaecker K; Lahortiga I; Mentens N; Folens C; Van Neste L; Bekaert S; Vandenberghe P; Odero MD; Marynen P; Cools J
Haematologica; 2008 Apr; 93(4):533-42. PubMed ID: 18322257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
